%0 Journal Article
%T SARS-CoV-2 Polymerase Chain Reaction Cycle Threshold Trends in Patients Who Are Immunocompromised and Implications for Isolation Precautions.
%A Harris CE
%A Vaidya V
%A Lan Z
%A Klompas M
%A Rhee C
%A Baden LR
%A Baker MA
%J Open Forum Infect Dis
%V 11
%N 7
%D 2024 Jul
%M 39077053
%F 4.423
%R 10.1093/ofid/ofae367
%X Among 495 patients who were immunocompromised and tested positive for SARS-CoV-2, polymerase chain reaction cycle thresholds remained <33 beyond 20 days more frequently in patients with hematologic malignancies, particularly those receiving B-cell-depleting or Bruton tyrosine kinase inhibitor therapy, as compared with those with solid organ malignancy (26% vs 5%).